Ameritas Investment Partners’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-5,048
| Closed | -$122K | – | 3306 |
|
2023
Q1 | $122K | Hold |
5,048
| – | – | ﹤0.01% | 1414 |
|
2022
Q4 | $45K | Buy |
5,048
+1,304
| +35% | +$11.6K | ﹤0.01% | 2132 |
|
2022
Q3 | $16K | Hold |
3,744
| – | – | ﹤0.01% | 2638 |
|
2022
Q2 | $14K | Hold |
3,744
| – | – | ﹤0.01% | 2733 |
|
2022
Q1 | $27K | Hold |
3,744
| – | – | ﹤0.01% | 2434 |
|
2021
Q4 | $21K | Hold |
3,744
| – | – | ﹤0.01% | 2634 |
|
2021
Q3 | $24K | Hold |
3,744
| – | – | ﹤0.01% | 2614 |
|
2021
Q2 | $32K | Hold |
3,744
| – | – | ﹤0.01% | 2472 |
|
2021
Q1 | $39K | Hold |
3,744
| – | – | ﹤0.01% | 2235 |
|
2020
Q4 | $63K | Hold |
3,744
| – | – | ﹤0.01% | 1849 |
|
2020
Q3 | $48K | Hold |
3,744
| – | – | ﹤0.01% | 1866 |
|
2020
Q2 | $53K | Buy |
+3,744
| New | +$53K | ﹤0.01% | 1792 |
|